Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
2016/09/15 by Rebecca Landy, Francesca Pesola, Alejandra Castañón +1 · 27 citations
Medicine · #Cervical Cancer and HPV Research #Endometrial and Cervical Cancer Treatments #Global Cancer Incidence and Screening
paper · pdf · doi:10.1038/bjc.2016.290
Abstract
BACKGROUND: It is well established that screening can prevent cervical cancer, but the magnitude of the impact of regular screening on cervical cancer mortality is unknown. METHODS: Population-based case-control study using prospectively recorded cervical screening data, England 1988-2013. Case women had cervical cancer diagnosed during April 2007-March 2013 aged 25-79 years (N=11 619). Two cancer-free controls were individually age matched to each case. We used conditional logistic regression to estimate the odds ratio (OR) of developing stage-specific cancer for women regularly screened or irregularly screened compared with women not screened in the preceding 15 years. Mortality was estimated from excess deaths within 5 years of diagnosis using stage-specific 5-year relative survival from England with adjustment for age within stage based on SEER (Surveillance, Epidemiology and End Results, USA) data. RESULTS: In women aged 35-64 years, regular screening is associated with a 67% (95% confidence interval (CI): 62-73%) reduction in stage 1A cancer and a 95% (95% CI: 94-97%) reduction in stage 3 or worse cervical cancer: the estimated OR comparing regular (⩽5.5yearly) screening to no (or minimal) screening are 0.18 (95% CI: 0.16-0.19) for cancer incidence and 0.08 (95% CI: 0.07-0.09) for mortality. It is estimated that in England screening currently prevents 70% (95% CI: 66-73%) of cervical cancer deaths (all ages); however, if everyone attended screening regularly, 83% (95% CI: 82-84%) could be prevented. CONCLUSIONS: The association between cervical cancer screening and incidence is stronger in more advanced stage cancers, and screening is more effective at preventing death from cancer than preventing cancer itself.
Cited by
- “I feel reassured, but there is no guarantee.” How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study
- Prevention and control of HPV-related cancers in people living with HIV
- Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. [europepmc]
- Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study. [europepmc]
- Shared Decision-Making and Women's Adherence to Breast and Cervical Cancer Screenings. [europepmc]
- Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. [europepmc]
- Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014. [europepmc]
- Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study. [europepmc]
- Impact of screening on cervical cancer incidence in England: a time trend analysis. [europepmc]
- Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016. [europepmc]
- Cancer overdiagnosis: a biological challenge and clinical dilemma. [europepmc]
- Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015. [europepmc]
- Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014. [europepmc]
- Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India. [europepmc]
- A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed. [europepmc]
- Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States. [europepmc]
- Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis. [europepmc]
- Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study. [europepmc]
- Cervical screening attendance and cervical cancer risk among women who have sex with women. [europepmc]
- Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women. [europepmc]
- Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer. [europepmc]
- Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials. [europepmc]
- Cervical cancer screening guidelines and screening practices in 11 countries: A systematic literature review. [europepmc]
- Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. [europepmc]
- HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK. [europepmc]
- 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis. [europepmc]
- Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen). [europepmc]
Related